Volume | 100 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
bioAffinity Technologies Inc | BIAFW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.39 | 0.39 |
Trades | Shares Traded | Average Volume |
---|---|---|
1 | 100 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
06:51:55 | formt | 100 | 0.3796 | USD |
bioAffinity Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.72M | 9.50M | - | 2.53M | -7.94M | -0.84 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News bioAffinity Technologies
Date | Time | Source | Heading |
---|---|---|---|
5/02/2024 | 07:00 | Business Wire | bioAffinity Technologies News Update |
4/24/2024 | 07:00 | Business Wire | bioAffinity Technologies Advances New Product Development.. |
4/09/2024 | 07:00 | Business Wire | bioAffinity Technologies Expands Campaign to Support.. |
4/01/2024 | 08:49 | Business Wire | bioAffinity Technologies Reports Fourth Quarter and Full.. |
3/08/2024 | 11:45 | Business Wire | bioAffinity Technologies Announces Closing of $2.5 Million.. |
3/06/2024 | 08:46 | Business Wire | bioAffinity Technologies Announces Pricing of $2.5 Million.. |
2/21/2024 | 07:00 | Business Wire | bioAffinity Technologies News Update |
1/30/2024 | 07:00 | Business Wire | bioAffinity Technologies In The News |
1/08/2024 | 07:00 | Business Wire | bioAffinity Technologies In the News |
12/05/2023 | 07:00 | Business Wire | bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its.. |
11/30/2023 | 07:00 | Business Wire | CMS Posts Final Payment Determination for bioAffinity.. |
11/28/2023 | 07:00 | Business Wire | bioAffinity Technologies VP David Elzi, Ph.D., Named to.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BIAFW Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers. |